To examine whether the increase in the number of mitotic cells by the compound was due to the promotion of mitotic entry or induction of mitotic arrest and death, we analyzed an apoptosis marker (caspase-3 cleavage) in RCC cells treated with SKPin C1. Here, CASP3 is linked to renal cell carcinoma.